Matrix control of pancreatic cancer: New insights into fibronectin signaling
M Topalovski, RA Brekken - Cancer letters, 2016 - Elsevier
Pancreatic ductal adenocarcinoma (PDA) is a highly metastatic disease that resists most
current therapies. A defining characteristic of PDA is an intense fibrotic response that …
current therapies. A defining characteristic of PDA is an intense fibrotic response that …
[HTML][HTML] Matrix control of pancreatic cancer: new insights into fibronectin signaling
M Topalovski, RA Brekken - Cancer letters, 2016 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDA) is a highly metastatic disease that resists most
current therapies. A defining characteristic of PDA is an intense fibrotic response that …
current therapies. A defining characteristic of PDA is an intense fibrotic response that …
[引用][C] Matrix control of pancreatic cancer: New insights into fibronectin signaling
M Topalovski, RA Brekken - Cancer Letters, 2016 - cir.nii.ac.jp
Matrix control of pancreatic cancer: New insights into fibronectin signaling | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Matrix control of pancreatic cancer: New insights into fibronectin signaling.
M Topalovski, RA Brekken - Cancer Letters, 2015 - europepmc.org
Pancreatic ductal adenocarcinoma (PDA) is a highly metastatic disease that resists most
current therapies. A defining characteristic of PDA is an intense fibrotic response that …
current therapies. A defining characteristic of PDA is an intense fibrotic response that …
Matrix control of pancreatic cancer: New insights into fibronectin signaling
M Topalovski, RA Brekken - Cancer letters, 2016 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDA) is a highly metastatic disease that resists most
current therapies. A defining characteristic of PDA is an intense fibrotic response that …
current therapies. A defining characteristic of PDA is an intense fibrotic response that …
[PDF][PDF] Matrix control of pancreatic cancer: New insights into fibronectin signaling
M Topalovski, RA Brekken - Cancer Letters, 2016 - researchgate.net
Pancreatic ductal adenocarcinoma (PDA) is a highly metastatic disease that resists most
current therapies. A defining characteristic of PDA is an intense fibrotic response that …
current therapies. A defining characteristic of PDA is an intense fibrotic response that …
Matrix control of pancreatic cancer: New insights into fibronectin signaling
M Topalovski, RA Brekken - Cancer Letters, 2016 - utsouthwestern.elsevierpure.com
Pancreatic ductal adenocarcinoma (PDA) is a highly metastatic disease that resists most
current therapies. A defining characteristic of PDA is an intense fibrotic response that …
current therapies. A defining characteristic of PDA is an intense fibrotic response that …
Matrix control of pancreatic cancer: New insights into fibronectin signaling
M Topalovski, RA Brekken - Cancer Letters, 2016 - infona.pl
Pancreatic ductal adenocarcinoma (PDA) is a highly metastatic disease that resists most
current therapies. A defining characteristic of PDA is an intense fibrotic response that …
current therapies. A defining characteristic of PDA is an intense fibrotic response that …